Infusions of allopregnanolone into the hippocampus and amygdala, but not into the nucleus accumbens and medial prefrontal cortex, produce antidepressant effects on the learned helplessness rats

Hippocampus
Yukihiko ShirayamaMasaomi Iyo

Abstract

Patients with depression showed a decrease in plasma and cerebrospinal fluid allopregnanolone (ALLO). But antidepressants increased the contents of ALLO in the rat brain. We examined the antidepressant-like effects of infusion of ALLO into the cerebral ventricle, hippocampus, amygdala, nucleus accumbens, or prefrontal cortex of learned helplessness (LH) rats (an animal model of depression). Of these regions, infusions of ALLO into the cerebral ventricle, the CA3 region of hippocampus, or the central region of amygdala exerted antidepressant-like effects. Infusion of ALLO into the hippocampal CA3 region or the central amygdala did not produce memory deficits or locomotor activation in the passive avoidance and open field tests. It is well documented that ALLO exerts its effects through GABA receptors. Therefore, we examined the antagonistic effects of flumazenil (a GABA receptor antagonist) on the antidepressant-like effects of ALLO. Coinfusion of flumazenil with ALLO into the hippocampal CA3 region, but not into the central amygdala, blocked the antidepressant-like effects of ALLO. However, coinfusion of (+)MK801 (an NMDA receptor antagonist), but not cycloheximide (a protein synthesis inhibitor), blocked the antidepressant-lik...Continue Reading

References

May 25, 1991·Proceedings of the National Academy of Sciences of the United States of America·R H PurdyS M Paul
Jul 8, 1990·The Journal of Comparative Neurology·C Gonzales, M F Chesselet
Feb 1, 1967·Journal of Comparative and Physiological Psychology·J B Overmier, M E Seligman
Dec 1, 1995·Brain Research. Molecular Brain Research·M OrchinikB S McEwen
Oct 29, 1996·Proceedings of the National Academy of Sciences of the United States of America·D P UzunovA Guidotti
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·V UzunovaA Guidotti
Jul 11, 1998·The American Journal of Psychiatry·E RomeoR Rupprecht
Aug 26, 1998·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·J G VeeningB Olivier
Nov 11, 1999·Proceedings of the National Academy of Sciences of the United States of America·L D Griffin, S H Mellon
Dec 13, 2000·Pharmacology, Biochemistry, and Behavior·R T KhistiS P Jain
Apr 17, 2002·Brain Research·Inga Maj JohanssonTorbjörn Bäckström
Aug 2, 2003·Biological Psychiatry·Yvette I Sheline
Sep 6, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Allon NechmadAbraham Weizman
Apr 4, 2006·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Agnieszka Basta-KaimWładysław Lasoń
May 22, 2007·Pharmacology & Therapeutics·Sheryl S SmithXiangping Zhou
Nov 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Roberto C Agís-BalboaAlessandro Guidotti
May 24, 2008·Biochemical and Biophysical Research Communications·Martin ElfversonTobias Johansson
May 27, 2009·Nature Reviews. Neuroscience·Yvonne M Ulrich-Lai, James P Herman
Jun 17, 2009·Psychopharmacology·Ciara McCabeCatherine J Harmer
Jul 17, 2009·The American Journal of Psychiatry·Etienne SibilleDavid A Lewis
Sep 18, 2009·Psychoneuroendocrinology·Jeremy J LambertDelia Belelli

❮ Previous
Next ❯

Citations

Nov 13, 2013·Progress in Neurobiology·Cornelius SchüleRainer Rupprecht
May 14, 2014·Canadian Journal of Physiology and Pharmacology·Hyo Geun KimMyung Sook Oh
Feb 5, 2014·Neurobiology of Learning and Memory·Janine BayerTobias Sommer
Jan 9, 2014·Psychopharmacology·Christopher D SchmoutzNicholas E Goeders
Oct 1, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Yukihiko ShirayamaKenji Hashimoto
Jan 14, 2012·Neuroscience Research·H KobayashiK Kaneko
Aug 17, 2014·Neuropharmacology·Paul D WhissellBeverley A Orser
Jan 9, 2015·The International Journal of Neuropsychopharmacology·Chun YangKenji Hashimoto
Sep 21, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Anjana Bali, Amteshwar Singh Jaggi
Jun 15, 2014·Frontiers in Neuroendocrinology·Benjamin G GunnDelia Belelli
Dec 25, 2012·Neuroscience and Biobehavioral Reviews·Paul WillnerCatherine Belzung
Dec 13, 2019·Biologie aujourd'hui·Nicolas Froger
Jul 28, 2017·Frontiers in Cellular Neuroscience·Bryan LeawHenrik Hagberg
Jun 29, 2018·Pharmacology & Therapeutics·Marina SchvererIsabelle Villey
Jun 3, 2021·International Journal of Molecular Sciences·Felipe Borges AlmeidaHelena Maria Tannhauser Barros
May 22, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Shiyi ChenYiping Ye

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.